| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 62 | 2024 | 146 | 10.650 |
Why?
|
| Huntingtin Protein | 58 | 2024 | 138 | 4.850 |
Why?
|
| Nerve Tissue Proteins | 42 | 2022 | 421 | 3.410 |
Why?
|
| RNA, Small Interfering | 29 | 2024 | 851 | 2.880 |
Why?
|
| Nuclear Proteins | 33 | 2017 | 759 | 2.220 |
Why?
|
| Neurons | 40 | 2019 | 858 | 2.220 |
Why?
|
| RNA Interference | 15 | 2024 | 589 | 2.180 |
Why?
|
| RNA, Messenger | 21 | 2024 | 1470 | 2.080 |
Why?
|
| Corpus Striatum | 28 | 2023 | 96 | 2.070 |
Why?
|
| Brain | 26 | 2018 | 1488 | 1.510 |
Why?
|
| Trinucleotide Repeats | 7 | 2016 | 20 | 1.370 |
Why?
|
| Mutant Proteins | 6 | 2018 | 105 | 1.200 |
Why?
|
| Neostriatum | 5 | 2023 | 25 | 1.160 |
Why?
|
| Disease Models, Animal | 24 | 2024 | 2062 | 1.130 |
Why?
|
| Animals | 115 | 2024 | 19613 | 1.100 |
Why?
|
| Genetic Therapy | 10 | 2021 | 734 | 1.100 |
Why?
|
| Mutation | 21 | 2024 | 2427 | 0.870 |
Why?
|
| Mice | 58 | 2024 | 10258 | 0.870 |
Why?
|
| Dependovirus | 8 | 2019 | 655 | 0.840 |
Why?
|
| Caudate Nucleus | 6 | 2018 | 25 | 0.820 |
Why?
|
| Gene Silencing | 14 | 2024 | 377 | 0.760 |
Why?
|
| Genetic Vectors | 8 | 2019 | 813 | 0.750 |
Why?
|
| Oligonucleotides | 4 | 2022 | 208 | 0.740 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2022 | 462 | 0.730 |
Why?
|
| 3' Untranslated Regions | 2 | 2018 | 84 | 0.710 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2018 | 87 | 0.700 |
Why?
|
| Pheochromocytoma | 5 | 2022 | 27 | 0.650 |
Why?
|
| Cerebral Cortex | 11 | 2015 | 253 | 0.650 |
Why?
|
| Protein Isoforms | 3 | 2024 | 195 | 0.650 |
Why?
|
| Central Nervous System | 5 | 2024 | 191 | 0.640 |
Why?
|
| Putamen | 3 | 2018 | 19 | 0.610 |
Why?
|
| RNA Editing | 2 | 2014 | 21 | 0.590 |
Why?
|
| Animals, Genetically Modified | 5 | 2020 | 281 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-fos | 12 | 2005 | 53 | 0.560 |
Why?
|
| Humans | 89 | 2024 | 59328 | 0.560 |
Why?
|
| MicroRNAs | 4 | 2018 | 617 | 0.560 |
Why?
|
| Virus Internalization | 1 | 2018 | 97 | 0.550 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 193 | 0.550 |
Why?
|
| Adrenal Gland Neoplasms | 5 | 2022 | 45 | 0.550 |
Why?
|
| Trinucleotide Repeat Expansion | 6 | 2023 | 33 | 0.540 |
Why?
|
| Suprachiasmatic Nucleus | 9 | 2005 | 141 | 0.540 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2018 | 133 | 0.490 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2014 | 16 | 0.480 |
Why?
|
| Substance P | 12 | 2002 | 45 | 0.470 |
Why?
|
| Transduction, Genetic | 5 | 2019 | 233 | 0.470 |
Why?
|
| Sheep | 6 | 2021 | 166 | 0.440 |
Why?
|
| Extracellular Vesicles | 3 | 2018 | 41 | 0.430 |
Why?
|
| Gene Expression | 6 | 2019 | 808 | 0.420 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2009 | 24 | 0.400 |
Why?
|
| Rats | 32 | 2018 | 1907 | 0.400 |
Why?
|
| Cells, Cultured | 24 | 2019 | 2103 | 0.400 |
Why?
|
| Mice, Transgenic | 16 | 2019 | 1221 | 0.390 |
Why?
|
| Cell Nucleus | 10 | 2024 | 603 | 0.380 |
Why?
|
| rab GTP-Binding Proteins | 6 | 2016 | 79 | 0.370 |
Why?
|
| Peptides | 9 | 2018 | 548 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2015 | 766 | 0.330 |
Why?
|
| Blood-Brain Barrier | 3 | 2019 | 82 | 0.330 |
Why?
|
| Drug Delivery Systems | 4 | 2018 | 307 | 0.330 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 1537 | 0.330 |
Why?
|
| Pituitary Gland, Anterior | 5 | 1988 | 30 | 0.320 |
Why?
|
| Membrane Proteins | 5 | 2021 | 843 | 0.310 |
Why?
|
| Brain Chemistry | 6 | 1999 | 80 | 0.310 |
Why?
|
| Circadian Rhythm | 9 | 2000 | 370 | 0.300 |
Why?
|
| Autophagy | 4 | 2016 | 205 | 0.290 |
Why?
|
| Transcription, Genetic | 6 | 2018 | 847 | 0.280 |
Why?
|
| Genome, Viral | 2 | 2018 | 121 | 0.280 |
Why?
|
| Exosomes | 2 | 2018 | 42 | 0.280 |
Why?
|
| Immunohistochemistry | 21 | 2005 | 846 | 0.270 |
Why?
|
| Germ-Line Mutation | 3 | 2021 | 47 | 0.260 |
Why?
|
| Sheep, Domestic | 2 | 2018 | 13 | 0.260 |
Why?
|
| Male | 44 | 2024 | 27509 | 0.260 |
Why?
|
| Blotting, Western | 15 | 2013 | 595 | 0.260 |
Why?
|
| Rats, Inbred Strains | 14 | 1992 | 151 | 0.250 |
Why?
|
| Diabetic Angiopathies | 3 | 1991 | 25 | 0.250 |
Why?
|
| Injections | 3 | 2018 | 79 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2007 | 214 | 0.230 |
Why?
|
| Liver | 3 | 2018 | 785 | 0.230 |
Why?
|
| Quinolinic Acid | 2 | 2002 | 4 | 0.230 |
Why?
|
| Coronary Disease | 3 | 1991 | 249 | 0.220 |
Why?
|
| MutS Homolog 3 Protein | 1 | 2023 | 4 | 0.220 |
Why?
|
| Transcription Factors | 5 | 2024 | 1456 | 0.220 |
Why?
|
| Axons | 10 | 1997 | 120 | 0.220 |
Why?
|
| fas Receptor | 1 | 2003 | 54 | 0.210 |
Why?
|
| Hepatitis | 1 | 2003 | 55 | 0.210 |
Why?
|
| Convection | 2 | 2013 | 10 | 0.210 |
Why?
|
| Cholesterol | 2 | 2018 | 255 | 0.200 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 304 | 0.200 |
Why?
|
| Light | 5 | 2005 | 201 | 0.200 |
Why?
|
| Basal Ganglia | 5 | 1992 | 30 | 0.200 |
Why?
|
| Endorphins | 6 | 1986 | 12 | 0.190 |
Why?
|
| Organophosphonates | 2 | 2021 | 21 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 3 | 2018 | 353 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 3189 | 0.190 |
Why?
|
| Autistic Disorder | 1 | 2024 | 167 | 0.190 |
Why?
|
| Gene Knock-In Techniques | 5 | 2015 | 34 | 0.190 |
Why?
|
| Microscopy, Electron | 14 | 1992 | 252 | 0.190 |
Why?
|
| Pituitary Neoplasms | 3 | 1997 | 23 | 0.180 |
Why?
|
| Enkephalins | 4 | 1986 | 15 | 0.180 |
Why?
|
| S100 Calcium Binding Protein G | 3 | 1997 | 7 | 0.180 |
Why?
|
| Disease Progression | 3 | 2020 | 1040 | 0.170 |
Why?
|
| Subcellular Fractions | 6 | 2012 | 66 | 0.170 |
Why?
|
| Alleles | 5 | 2022 | 425 | 0.170 |
Why?
|
| Kidney | 3 | 2018 | 391 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 127 | 0.170 |
Why?
|
| Endosomes | 4 | 2009 | 170 | 0.170 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1977 | 0.170 |
Why?
|
| Thalamus | 2 | 1991 | 62 | 0.170 |
Why?
|
| Female | 33 | 2024 | 30827 | 0.170 |
Why?
|
| Cisterna Magna | 1 | 2019 | 14 | 0.170 |
Why?
|
| Antigens, Ly | 1 | 2019 | 40 | 0.170 |
Why?
|
| HeLa Cells | 7 | 2018 | 527 | 0.170 |
Why?
|
| DNA-Binding Proteins | 6 | 2015 | 1128 | 0.170 |
Why?
|
| Neuropeptides | 2 | 2019 | 83 | 0.170 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 5 | 2018 | 248 | 0.170 |
Why?
|
| Somatostatin | 3 | 1984 | 21 | 0.160 |
Why?
|
| Actinin | 1 | 2019 | 9 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2005 | 569 | 0.160 |
Why?
|
| Exercise Test | 3 | 1991 | 233 | 0.160 |
Why?
|
| Synaptosomes | 3 | 2015 | 16 | 0.160 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 16 | 0.160 |
Why?
|
| Lipids | 2 | 2018 | 305 | 0.160 |
Why?
|
| Microglia | 2 | 2018 | 227 | 0.160 |
Why?
|
| Neurites | 2 | 1999 | 22 | 0.160 |
Why?
|
| Middle Aged | 23 | 2021 | 16238 | 0.160 |
Why?
|
| Adult | 23 | 2021 | 15735 | 0.160 |
Why?
|
| Endocrinology | 1 | 2018 | 21 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 75 | 0.160 |
Why?
|
| Thyroxine | 5 | 1988 | 53 | 0.150 |
Why?
|
| RNA-Induced Silencing Complex | 3 | 2017 | 67 | 0.150 |
Why?
|
| Neurotensin | 5 | 1997 | 6 | 0.150 |
Why?
|
| Peptide Fragments | 5 | 2012 | 353 | 0.150 |
Why?
|
| Wool | 1 | 2018 | 5 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 11 | 1997 | 104 | 0.150 |
Why?
|
| Electrolytes | 1 | 2018 | 24 | 0.150 |
Why?
|
| Internal Capsule | 1 | 2018 | 12 | 0.150 |
Why?
|
| Immunoassay | 1 | 2018 | 51 | 0.150 |
Why?
|
| Aged | 17 | 2021 | 13293 | 0.150 |
Why?
|
| Serogroup | 1 | 2018 | 31 | 0.150 |
Why?
|
| Genes, fos | 2 | 1996 | 18 | 0.150 |
Why?
|
| Vinyl Compounds | 1 | 2017 | 6 | 0.150 |
Why?
|
| DNA Repeat Expansion | 1 | 2018 | 53 | 0.140 |
Why?
|
| Parenchymal Tissue | 1 | 2017 | 4 | 0.140 |
Why?
|
| Histones | 3 | 2015 | 463 | 0.140 |
Why?
|
| Myeloid Cells | 2 | 2017 | 92 | 0.140 |
Why?
|
| Phospholipids | 2 | 2009 | 79 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1997 | 14 | 0.140 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 1997 | 7 | 0.140 |
Why?
|
| Endocytosis | 4 | 2009 | 148 | 0.140 |
Why?
|
| Tissue Distribution | 7 | 2018 | 282 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 1990 | 79 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 34 | 0.130 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2001 | 75 | 0.130 |
Why?
|
| Mass Screening | 1 | 2022 | 643 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2009 | 379 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2019 | 2890 | 0.130 |
Why?
|
| Paraganglioma | 1 | 2015 | 4 | 0.130 |
Why?
|
| Synapses | 9 | 1992 | 177 | 0.130 |
Why?
|
| Exons | 2 | 2016 | 193 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 294 | 0.130 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 75 | 0.130 |
Why?
|
| Sp1 Transcription Factor | 1 | 1995 | 21 | 0.130 |
Why?
|
| Macaca fascicularis | 8 | 1990 | 47 | 0.120 |
Why?
|
| Glycerophospholipids | 1 | 2015 | 4 | 0.120 |
Why?
|
| Globus Pallidus | 4 | 1992 | 24 | 0.120 |
Why?
|
| Phosphatidic Acids | 1 | 2015 | 7 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2015 | 94 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 22 | 0.120 |
Why?
|
| Nerve Fibers | 5 | 1988 | 29 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2016 | 185 | 0.110 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 37 | 0.110 |
Why?
|
| Benzothiazoles | 1 | 2014 | 17 | 0.110 |
Why?
|
| Chloroquine | 1 | 2014 | 48 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 5067 | 0.110 |
Why?
|
| Base Sequence | 8 | 2014 | 1312 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 229 | 0.110 |
Why?
|
| Species Specificity | 4 | 2019 | 336 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 416 | 0.110 |
Why?
|
| Hypothyroidism | 4 | 1988 | 39 | 0.110 |
Why?
|
| Physicians | 1 | 2018 | 436 | 0.110 |
Why?
|
| Software | 2 | 2014 | 367 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 525 | 0.110 |
Why?
|
| Allelic Imbalance | 1 | 2013 | 6 | 0.110 |
Why?
|
| In Situ Hybridization | 6 | 2005 | 215 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2013 | 28 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 1995 | 659 | 0.110 |
Why?
|
| Infusions, Spinal | 1 | 2012 | 3 | 0.100 |
Why?
|
| Calpain | 2 | 2003 | 7 | 0.100 |
Why?
|
| Methionine | 1 | 2013 | 56 | 0.100 |
Why?
|
| Uremia | 2 | 1983 | 9 | 0.100 |
Why?
|
| Lysosomes | 2 | 2006 | 162 | 0.100 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 3 | 2016 | 9 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2014 | 130 | 0.100 |
Why?
|
| Computational Biology | 1 | 2014 | 325 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 98 | 0.100 |
Why?
|
| Cell Membrane | 4 | 2019 | 492 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 80 | 0.100 |
Why?
|
| Hypothalamus | 5 | 1992 | 120 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2016 | 576 | 0.100 |
Why?
|
| Biogenic Monoamines | 1 | 1992 | 5 | 0.100 |
Why?
|
| Facial Pain | 1 | 1992 | 2 | 0.100 |
Why?
|
| Receptors, Dopamine | 3 | 2002 | 14 | 0.100 |
Why?
|
| Cell Count | 3 | 2016 | 129 | 0.100 |
Why?
|
| Receptors, Dopamine D1 | 5 | 2002 | 22 | 0.100 |
Why?
|
| Macaca | 2 | 1989 | 30 | 0.100 |
Why?
|
| Neuronavigation | 1 | 2011 | 13 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1990 | 315 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2014 | 461 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 111 | 0.100 |
Why?
|
| Diabetic Neuropathies | 2 | 1990 | 9 | 0.100 |
Why?
|
| Capsaicin | 2 | 1990 | 22 | 0.100 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2011 | 28 | 0.100 |
Why?
|
| Heterozygote | 2 | 2002 | 168 | 0.090 |
Why?
|
| Trigeminal Nerve | 1 | 1991 | 5 | 0.090 |
Why?
|
| Thallium Radioisotopes | 1 | 1991 | 9 | 0.090 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2011 | 71 | 0.090 |
Why?
|
| Interneurons | 1 | 1991 | 22 | 0.090 |
Why?
|
| Chromatin | 1 | 2015 | 594 | 0.090 |
Why?
|
| Cytokines | 1 | 2015 | 906 | 0.090 |
Why?
|
| Dendrites | 7 | 2001 | 56 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2014 | 325 | 0.090 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Antigens | 1 | 1991 | 146 | 0.090 |
Why?
|
| Trigeminal Nuclei | 1 | 1990 | 2 | 0.090 |
Why?
|
| Caspases | 2 | 2001 | 164 | 0.090 |
Why?
|
| Cathepsin D | 5 | 2016 | 11 | 0.090 |
Why?
|
| Synaptic Vesicles | 5 | 2015 | 26 | 0.090 |
Why?
|
| Enkephalin, Leucine | 3 | 1984 | 7 | 0.090 |
Why?
|
| In Vitro Techniques | 4 | 2004 | 475 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 41 | 0.080 |
Why?
|
| Substantia Nigra | 4 | 1986 | 15 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 48 | 0.080 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hemodynamics | 1 | 1991 | 232 | 0.080 |
Why?
|
| Genetic Carrier Screening | 1 | 2009 | 14 | 0.080 |
Why?
|
| Peptide Nucleic Acids | 1 | 2009 | 17 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 2 | 1986 | 23 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2019 | 243 | 0.080 |
Why?
|
| Guanine Nucleotides | 1 | 2008 | 4 | 0.080 |
Why?
|
| Gene Targeting | 2 | 2006 | 82 | 0.080 |
Why?
|
| Microscopy, Confocal | 4 | 2019 | 219 | 0.080 |
Why?
|
| Cell Death | 3 | 2010 | 267 | 0.080 |
Why?
|
| Dihydrotestosterone | 2 | 1985 | 17 | 0.080 |
Why?
|
| Dogfish | 1 | 1988 | 1 | 0.080 |
Why?
|
| Salt Gland | 1 | 1988 | 1 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2010 | 280 | 0.080 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1988 | 23 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2017 | 5142 | 0.070 |
Why?
|
| Sharks | 1 | 1988 | 7 | 0.070 |
Why?
|
| Neuropil Threads | 1 | 2007 | 2 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 2 | 2018 | 30 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2007 | 8 | 0.070 |
Why?
|
| Histamine | 1 | 1987 | 27 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 439 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 2034 | 0.070 |
Why?
|
| DNA Probes | 3 | 1997 | 35 | 0.070 |
Why?
|
| Spinal Cord | 5 | 1984 | 195 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 1987 | 28 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2007 | 29 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 150 | 0.070 |
Why?
|
| Fibroblasts | 4 | 2019 | 367 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 396 | 0.070 |
Why?
|
| Phosphorylcholine | 2 | 2018 | 41 | 0.070 |
Why?
|
| Inclusion Bodies | 4 | 1999 | 14 | 0.070 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 177 | 0.070 |
Why?
|
| Estradiol | 2 | 1985 | 242 | 0.070 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 116 | 0.070 |
Why?
|
| Cerebellum | 4 | 2015 | 94 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2016 | 17 | 0.070 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 26 | 0.070 |
Why?
|
| Genotype | 2 | 2019 | 644 | 0.070 |
Why?
|
| Nucleotides | 1 | 2006 | 42 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2021 | 2437 | 0.070 |
Why?
|
| Cathepsins | 1 | 2006 | 32 | 0.060 |
Why?
|
| RNA, Double-Stranded | 2 | 2023 | 108 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 502 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 677 | 0.060 |
Why?
|
| Androgens | 1 | 1985 | 49 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 50 | 0.060 |
Why?
|
| beta-Lipotropin | 2 | 1983 | 2 | 0.060 |
Why?
|
| Transcription Factor TFIIH | 2 | 2016 | 5 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 78 | 0.060 |
Why?
|
| Cell Line | 5 | 2015 | 2014 | 0.060 |
Why?
|
| Cell Differentiation | 4 | 2019 | 1295 | 0.060 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 77 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 1985 | 74 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 131 | 0.060 |
Why?
|
| Adolescent | 7 | 2015 | 5917 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2006 | 112 | 0.060 |
Why?
|
| Estrogens | 1 | 1985 | 113 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2003 | 253 | 0.060 |
Why?
|
| Cytoplasm | 3 | 2000 | 273 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2004 | 53 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2002 | 22 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2000 | 90 | 0.060 |
Why?
|
| Cell Line, Transformed | 4 | 2009 | 97 | 0.060 |
Why?
|
| Calcium | 2 | 2001 | 555 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 99 | 0.060 |
Why?
|
| Phagosomes | 1 | 2004 | 44 | 0.060 |
Why?
|
| Protein Transport | 3 | 2010 | 394 | 0.060 |
Why?
|
| Pain | 1 | 1987 | 406 | 0.060 |
Why?
|
| RNA, Antisense | 1 | 2003 | 48 | 0.050 |
Why?
|
| Calbindins | 3 | 1997 | 10 | 0.050 |
Why?
|
| Protein Binding | 4 | 2011 | 1550 | 0.050 |
Why?
|
| Weight Gain | 1 | 2024 | 161 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Axonal Transport | 4 | 1999 | 31 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2017 | 861 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2003 | 101 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2022 | 3 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2022 | 8 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2003 | 90 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 663 | 0.050 |
Why?
|
| Darkness | 2 | 1994 | 22 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2022 | 41 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 65 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 276 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 68 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 19 | 0.050 |
Why?
|
| Pedigree | 2 | 2005 | 190 | 0.050 |
Why?
|
| Transferrin | 3 | 2009 | 67 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2024 | 336 | 0.050 |
Why?
|
| Thyroidectomy | 3 | 1988 | 32 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 158 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2001 | 89 | 0.050 |
Why?
|
| Photoperiod | 2 | 2005 | 40 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2001 | 41 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2002 | 219 | 0.050 |
Why?
|
| Time Factors | 5 | 2005 | 3567 | 0.050 |
Why?
|
| Age of Onset | 1 | 2001 | 173 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 10 | 0.050 |
Why?
|
| Thyrotropin | 3 | 1988 | 33 | 0.050 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2 | 1991 | 2 | 0.050 |
Why?
|
| Wheat Germ Agglutinins | 2 | 1991 | 8 | 0.040 |
Why?
|
| Horseradish Peroxidase | 2 | 1991 | 16 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2001 | 216 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 82 | 0.040 |
Why?
|
| Nelson Syndrome | 1 | 1980 | 1 | 0.040 |
Why?
|
| Cyproheptadine | 1 | 1980 | 2 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 120 | 0.040 |
Why?
|
| Calbindin 1 | 2 | 1991 | 2 | 0.040 |
Why?
|
| Ion Channels | 1 | 2000 | 87 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2020 | 8 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 2000 | 7 | 0.040 |
Why?
|
| Radioimmunoassay | 4 | 1983 | 56 | 0.040 |
Why?
|
| Synapsins | 2 | 2016 | 7 | 0.040 |
Why?
|
| Transfection | 4 | 2005 | 673 | 0.040 |
Why?
|
| Arginine Vasopressin | 1 | 2000 | 20 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 1997 | 22 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 4 | 1986 | 18 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 42 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2021 | 133 | 0.040 |
Why?
|
| beta-Endorphin | 3 | 1986 | 8 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 43 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2015 | 26 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 72 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 55 | 0.040 |
Why?
|
| Phenotype | 2 | 2001 | 1157 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 66 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 19 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 125 | 0.040 |
Why?
|
| Colforsin | 1 | 1999 | 24 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 175 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 220 | 0.040 |
Why?
|
| Swine | 1 | 2020 | 338 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2018 | 9 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 875 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 26 | 0.040 |
Why?
|
| Mannitol | 1 | 2018 | 14 | 0.040 |
Why?
|
| Propylene Glycols | 1 | 2018 | 9 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 172 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4320 | 0.040 |
Why?
|
| Cushing Syndrome | 2 | 1993 | 6 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 211 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2017 | 1125 | 0.040 |
Why?
|
| Prolactin | 3 | 1988 | 40 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 18 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 549 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2018 | 59 | 0.040 |
Why?
|
| Apoptosis | 2 | 2000 | 1038 | 0.040 |
Why?
|
| Dopamine | 1 | 1999 | 101 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2009 | 14 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 155 | 0.040 |
Why?
|
| Telephone | 1 | 2018 | 121 | 0.040 |
Why?
|
| Genomics | 2 | 2014 | 314 | 0.040 |
Why?
|
| Mammals | 1 | 1999 | 204 | 0.040 |
Why?
|
| Astrocytes | 1 | 2018 | 115 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1983 | 198 | 0.040 |
Why?
|
| Proteome | 1 | 2018 | 135 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1997 | 41 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 36 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2016 | 1988 | 0.040 |
Why?
|
| Exoribonucleases | 1 | 2017 | 25 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 1997 | 22 | 0.040 |
Why?
|
| Biological Transport | 2 | 2014 | 287 | 0.040 |
Why?
|
| Mitochondria | 1 | 2000 | 333 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1997 | 26 | 0.040 |
Why?
|
| Acromegaly | 1 | 1997 | 2 | 0.040 |
Why?
|
| Cats | 2 | 2015 | 81 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 111 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 116 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 83 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2002 | 306 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1997 | 101 | 0.030 |
Why?
|
| Hyperthyroidism | 3 | 1985 | 17 | 0.030 |
Why?
|
| Luteinizing Hormone | 2 | 1988 | 98 | 0.030 |
Why?
|
| Drug Stability | 1 | 2017 | 139 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2016 | 14 | 0.030 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2016 | 7 | 0.030 |
Why?
|
| RNA Stability | 1 | 2017 | 93 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1996 | 28 | 0.030 |
Why?
|
| Proteins | 1 | 2002 | 742 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Child | 3 | 2015 | 4300 | 0.030 |
Why?
|
| Visual Perception | 1 | 1996 | 42 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 231 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 4 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 85 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2016 | 17 | 0.030 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2018 | 300 | 0.030 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2015 | 9 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 397 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2015 | 11 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 36 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 1987 | 22 | 0.030 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2015 | 12 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 32 | 0.030 |
Why?
|
| Mosaicism | 1 | 1995 | 25 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 97 | 0.030 |
Why?
|
| Ovariectomy | 2 | 1986 | 97 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 102 | 0.030 |
Why?
|
| Exome | 1 | 2015 | 73 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 191 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 1987 | 247 | 0.030 |
Why?
|
| Base Pair Mismatch | 2 | 2006 | 36 | 0.030 |
Why?
|
| Base Pairing | 2 | 2006 | 36 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 73 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 159 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2006 | 134 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 188 | 0.030 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 31 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1986 | 148 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 243 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 109 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1582 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 321 | 0.030 |
Why?
|
| Enkephalin, Methionine | 2 | 2002 | 9 | 0.030 |
Why?
|
| Superoxide Dismutase | 2 | 2006 | 213 | 0.030 |
Why?
|
| COS Cells | 2 | 2005 | 174 | 0.030 |
Why?
|
| Cell Survival | 2 | 2010 | 553 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 285 | 0.030 |
Why?
|
| Antimalarials | 1 | 2014 | 68 | 0.030 |
Why?
|
| Ganglia, Spinal | 2 | 1984 | 22 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1993 | 45 | 0.030 |
Why?
|
| Biological Clocks | 1 | 1993 | 69 | 0.030 |
Why?
|
| Osteoblasts | 2 | 1992 | 204 | 0.030 |
Why?
|
| Biotin | 2 | 2009 | 52 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2014 | 375 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1983 | 65 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 119 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2012 | 4 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1455 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 35 | 0.020 |
Why?
|
| Sex Factors | 2 | 1985 | 959 | 0.020 |
Why?
|
| Reticulocytes | 1 | 2012 | 11 | 0.020 |
Why?
|
| Trigeminal Ganglion | 1 | 1992 | 4 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1992 | 6 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 135 | 0.020 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1992 | 7 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1992 | 8 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1992 | 12 | 0.020 |
Why?
|
| Detergents | 1 | 2012 | 35 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2012 | 65 | 0.020 |
Why?
|
| Half-Life | 2 | 1982 | 70 | 0.020 |
Why?
|
| Kinetics | 2 | 2003 | 733 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 75 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 304 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 58 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 2 | 1981 | 42 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2005 | 166 | 0.020 |
Why?
|
| Immunochemistry | 2 | 1994 | 11 | 0.020 |
Why?
|
| Models, Biological | 2 | 2009 | 1140 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 173 | 0.020 |
Why?
|
| Epitopes | 2 | 2004 | 298 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 2009 | 124 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 330 | 0.020 |
Why?
|
| Quinolinic Acids | 1 | 1991 | 2 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1549 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2004 | 139 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 8 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 1990 | 24 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 101 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1990 | 27 | 0.020 |
Why?
|
| Osteocalcin | 1 | 1990 | 48 | 0.020 |
Why?
|
| Calcitriol | 1 | 1990 | 22 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 116 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 104 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 697 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 96 | 0.020 |
Why?
|
| Immune Sera | 1 | 1990 | 35 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 256 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 5975 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1990 | 96 | 0.020 |
Why?
|
| Maleimides | 1 | 2010 | 7 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2010 | 31 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 547 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1990 | 39 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2009 | 7 | 0.020 |
Why?
|
| Clone Cells | 2 | 2000 | 106 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2009 | 35 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2009 | 6 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 55 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 107 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 68 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 195 | 0.020 |
Why?
|
| Indoles | 1 | 2010 | 97 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 1990 | 855 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 201 | 0.020 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Clathrin | 2 | 1999 | 23 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 353 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 168 | 0.020 |
Why?
|
| Histocytochemistry | 2 | 1986 | 48 | 0.020 |
Why?
|
| Palliative Care | 1 | 1990 | 202 | 0.020 |
Why?
|
| Family | 1 | 2010 | 219 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 454 | 0.020 |
Why?
|
| Neuroblastoma | 2 | 1999 | 85 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 357 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1279 | 0.020 |
Why?
|
| Skin Tests | 1 | 1987 | 21 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 1990 | 266 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1987 | 64 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 31 | 0.020 |
Why?
|
| Base Composition | 1 | 2006 | 27 | 0.020 |
Why?
|
| Gold | 1 | 1989 | 227 | 0.020 |
Why?
|
| Purines | 1 | 2006 | 40 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2006 | 58 | 0.020 |
Why?
|
| Median Eminence | 1 | 1986 | 2 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1986 | 17 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1986 | 19 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 1990 | 2323 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 29 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Methimazole | 1 | 1985 | 8 | 0.020 |
Why?
|
| Orchiectomy | 1 | 1985 | 28 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 170 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 26 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 24 | 0.020 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2005 | 3 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 32 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2005 | 29 | 0.020 |
Why?
|
| Neural Pathways | 1 | 1986 | 97 | 0.020 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2005 | 16 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1985 | 49 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 607 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 1985 | 50 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 49 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2005 | 71 | 0.020 |
Why?
|
| Tetraethylammonium | 1 | 2004 | 8 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 1987 | 240 | 0.020 |
Why?
|
| Cesium | 1 | 2004 | 6 | 0.020 |
Why?
|
| Hypertension | 1 | 1991 | 600 | 0.020 |
Why?
|
| Castration | 1 | 1984 | 42 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 53 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2004 | 25 | 0.020 |
Why?
|
| Estrus | 1 | 1984 | 27 | 0.020 |
Why?
|
| Testosterone | 1 | 1985 | 118 | 0.020 |
Why?
|
| Static Electricity | 1 | 2005 | 165 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 125 | 0.010 |
Why?
|
| Benzofurans | 1 | 1984 | 10 | 0.010 |
Why?
|
| Dynorphins | 1 | 1984 | 1 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 136 | 0.010 |
Why?
|
| Amiodarone | 1 | 1984 | 21 | 0.010 |
Why?
|
| Iodine | 1 | 1984 | 21 | 0.010 |
Why?
|
| Lactation | 1 | 1984 | 70 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1984 | 26 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1984 | 26 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 167 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1984 | 123 | 0.010 |
Why?
|
| Dynamins | 1 | 2004 | 12 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 300 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 338 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1991 | 675 | 0.010 |
Why?
|
| Genome, Human | 1 | 2005 | 219 | 0.010 |
Why?
|
| Neuroglia | 1 | 1984 | 79 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1983 | 5 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2004 | 67 | 0.010 |
Why?
|
| Ciliary Body | 1 | 1983 | 11 | 0.010 |
Why?
|
| Tegmentum Mesencephali | 1 | 1983 | 6 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 59 | 0.010 |
Why?
|
| Hippocampus | 2 | 1997 | 238 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 77 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 125 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1991 | 3095 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1093 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 48 | 0.010 |
Why?
|
| Drosophila | 1 | 2006 | 419 | 0.010 |
Why?
|
| RNA Helicases | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 375 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 103 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2002 | 13 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 36 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 148 | 0.010 |
Why?
|
| Bromocriptine | 1 | 1982 | 2 | 0.010 |
Why?
|
| Sodium Oxybate | 1 | 2001 | 2 | 0.010 |
Why?
|
| Epinephrine | 1 | 1982 | 45 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 79 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 288 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2002 | 143 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1983 | 184 | 0.010 |
Why?
|
| Pituitary Gland | 2 | 1992 | 49 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1981 | 46 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1982 | 99 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1981 | 13 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1370 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 291 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2001 | 105 | 0.010 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2000 | 1 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 363 | 0.010 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2000 | 13 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 2000 | 19 | 0.010 |
Why?
|
| Vacuoles | 1 | 2000 | 27 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 56 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1518 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1981 | 191 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2000 | 61 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1980 | 12 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1980 | 14 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1980 | 24 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1981 | 150 | 0.010 |
Why?
|
| Risk Factors | 1 | 1990 | 4999 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 480 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1999 | 11 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 1999 | 21 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 21 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 99 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 187 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1999 | 134 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 404 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 580 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1997 | 31 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 1997 | 26 | 0.010 |
Why?
|
| Microtubules | 1 | 1999 | 211 | 0.010 |
Why?
|
| Dynactin Complex | 1 | 1997 | 6 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 35 | 0.010 |
Why?
|
| Pregnancy | 1 | 1984 | 2352 | 0.010 |
Why?
|
| Mitosis | 1 | 1999 | 208 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 177 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1996 | 93 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 183 | 0.010 |
Why?
|
| Autoradiography | 1 | 1996 | 53 | 0.010 |
Why?
|
| Cricetinae | 1 | 1996 | 377 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 323 | 0.010 |
Why?
|
| Efferent Pathways | 2 | 1987 | 12 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1994 | 41 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 880 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 43 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 182 | 0.010 |
Why?
|
| Motor Activity | 1 | 1996 | 342 | 0.010 |
Why?
|
| Limbic System | 1 | 1992 | 27 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1992 | 18 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 11 | 0.010 |
Why?
|
| Skull | 1 | 1992 | 57 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1990 | 8 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1990 | 53 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1990 | 29 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1990 | 17 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1990 | 113 | 0.010 |
Why?
|
| Cell Division | 1 | 1990 | 442 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 195 | 0.000 |
Why?
|
| Afferent Pathways | 1 | 1987 | 17 | 0.000 |
Why?
|
| Aging | 1 | 1992 | 723 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 793 | 0.000 |
Why?
|
| Triiodothyronine, Reverse | 1 | 1984 | 2 | 0.000 |
Why?
|
| Thyroglobulin | 1 | 1984 | 9 | 0.000 |
Why?
|
| Goiter | 1 | 1984 | 9 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1984 | 26 | 0.000 |
Why?
|
| Italy | 1 | 1984 | 62 | 0.000 |
Why?
|
| Periaqueductal Gray | 1 | 1983 | 3 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1984 | 174 | 0.000 |
Why?
|
| Receptors, Opioid | 1 | 1982 | 14 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1982 | 40 | 0.000 |
Why?
|
| Digestive System | 1 | 1982 | 25 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1982 | 30 | 0.000 |
Why?
|
| Neurotransmitter Agents | 1 | 1982 | 41 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1984 | 204 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 306 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 83 | 0.000 |
Why?
|
| Risk | 1 | 1980 | 371 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1980 | 142 | 0.000 |
Why?
|
| Massachusetts | 1 | 1984 | 2083 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1980 | 523 | 0.000 |
Why?
|
| Prognosis | 1 | 1980 | 1564 | 0.000 |
Why?
|